Doktor axborotnomasi 2022, №2.2 (104)

Maqola mavzusi

REPRODUKTIV YOSHIDAGI AYOLLARDA TUXUMDONLARNING POLIKISTOZ SINDROMI KELIB CHIQISHINING ASOSIY SABABLARINI ANIQLASH (32-35)

Mualliflar

Gul Ahmad Tanish

Muassasa

Balx universiteti, Mozori Sharif, Afgoniston

Annotatsiya

Tadqiqot maqsadi. Ushbu olib borilgan tadqiqotda biz tuxumdonlar polikistoz sindromi bilan og`rigan bemor-larni anamnestik, klinik, gormonal va ultratovush tekshiruvlar, demografik holati, shuningdek, gormonal kasalliklari, tana vazni va qondagi insulin darajasi o'rtasidagi bog'liqlikni o'rganishni maqsad qildik. Tadqiqot natijalari: eng keng tarqalgan klinik belgilar: hayz davrining buzilishi (100%), genetik omil (6,5%), girsutizm (62%) va semizlik (25%). Eng ko'p uchraydigan gormonal kasalliklar: testosteronning ortishi (32,5%), LG /FSG nisbati > 2 (25%), insulin qarshiligi (12,2%), mos ravishda GTT buzilishi (17,5%) va giperinsulinemiya (10%), hisoblanadi. Ultratovush tek-shiruvi 18,7% hollarda aniq natija bera olmadi.

Kalit so'zlar

tuxumdon polikistoz sindromi, giperandrogeniniya, hayz davrining buzilishi, girsutizm.

Adabiyotlar

1. Г.Д. Матризаева Cиндром поликистозных яичников был и остаѐтся проблемой научной и практической медицины // Вестник врача, № 4, 2018. С.109-114. 2. Б. Б. Негмаджанов, М. Н. Адылова, А. Э. Абдуллаева, Г. Т. Раббимова, Ф. И. Ганиев, В. О. Ким Қин ва ба-чадон аплазиясида тухумдонлар поликистози синдроми // Доктор ахборотномаси, № 2 (99), 2021. С.161-165. DOI: 10.38095/2181-466X-2021992-161-165 3. Birdak MA, Farguhar CM, White HO. Association between polycystic ovaries and extent of coronary artery dis-ease in women having cardiac catheterization. // Ann J Intern Med. 1997,126:32. 4. Diamamati E, Kandar A, Chryssa R, Kouls .A survey of the polycystic ovary syndrome in the Greek Islan of Leb-sos: Hormonal metabolic profile.- // J Pf. Clinical – Endocrin & metabol. 1999: 4006-4011. 5. Dunaif A. Hyperandrogenic Anovaulation ( P.C.O.S ) :A unique disorder of insulin action associated with an in-creased risk of NIDDM // AM J Med. 1995,98(1A) :336. 6. Falsett L, Efithrriou G. Hyper insulinemia in the polycystic ovary syndrome. A clinical endocrine and metabolic study in 240 patients. Gyn. // End. 1996. 10 :319-326. 7. Fitsch G, Hanzal R, Jensen D, Hacker N.F. Endometrial cancer in premenopausal women 45 years and younger.// Obstect- Gynecol , 2015, 85: 504. 8. Frank . S. Polysystic ovary syndrome.// New Eng1 J Med. 2016, 333:853-854. 9. Jahafar S, Eden J.A, Waren P, Sepplam Ngvyen T.V. A twin study of polycystic ovary syndrome // Fertil-Steril, 1995,63:78-478. 10. Kinara I, Togasgi K, Kawakan s, Nakanoy, Takakora K, Mori T, Konish J, Polycystic ovaries :Implications of Di-agnosis with MRI imaging // Radiology. 1996.201:549. 11. Leon S, Robert H. Glass, Nathan G.klse. Clinical gynecologic endocrinology infertility./ 6th ed. Lippincott Wil-liams & Wilkins 2018, 487 -523. 12. Suterlin M, Steck T. Sensitivity of plasma insulin level in obese and non obese women with functional hyper an-drogenism. //Gyn-End.2017,9:34-44. 13. Wild RA, Alaupovic P, Parker IJ. Lipid and Apolipoprotein abnormalities in hirsute women and association with insulin resistance .// Am J Obstet Gynecol. 1992,166:1191.